Clinical trial
Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80
NCT00163566 · ASCEND Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00163566 |
|---|---|
| Title | Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80 |
| Official title | A Phase II, Placebo-Controlled, Double-Blind, Dose-Ranging (35mg/Day or 70 mg/Day), Randomized, Study of Cutaneous Dihydrotestosterone (DHT)-Gel (0.7% Hydroalcoholic Gel) in Older Hypogonadal Males Ages 55-80 Years: Effect on Body Composition, Libido, and Physical and Sexual Functioning |
| Lead sponsor | ASCEND Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypogonadism, Late Onset Hypogonadism, Low Testosterone |
| Intervention type | Drug |
| Interventions | Dihydrotestosterone (0.7%) in hydroalcoholic gel |
| Enrollment | 128 |
| Start date | Oct 1, 2004 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 25, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Aug 15, 2022 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: